Navigation Links
Mr. Tad Ballantyne to Join Mach One Board of Directors
Date:12/1/2008

BELGIUM, Wisc., Dec. 1 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), a biological solutions company that develops products that produce a positive long term benefit to the agricultural and consumer market, announced today that Mr. Tad Ballantyne will join the Company's Board of Directors effective upon the closing of the acquisition of Pacific Rim Foods by Mach One this month.

Mr. Ballantyne is an officer and/or director of a number of public and private companies and is an active participant within each of these companies.

Ballantyne is CEO and director of Hoopeston Foods Inc., a private company engaged in the shelf stable food processing business. Ballantyne is also an officer and director of Thomsen Group LLC a stainless steel equipment business in USA.

In the public sector, Ballantyne is a director and the audit chairman of Life Partners Holdings Inc a public company engaged in the financial services sector whose market value during his tenure has increased from $40 million to over $400 million. Ballantyne is also co-chairman of Zeehan Zinc Ltd. (a London Stock Exchange AIM listed company engaged in the metals and mining sector that recently received shareholder approval to accept a controlling interest from Creat Group -- a private company in China. Ballantyne is also a director of Empire Energy Corporation International a company engaged in the oil & gas sector.

Ballantyne received his degree in Business Management from The University of Wisconsin. Ballantyne has also been involved over the last 20 years in the acquisition and turnaround of troubled subsidiaries of public and private firms. Ballantyne is also an advisor to a number of China based financial services and investment holding companies.

Monte Tobin, President and CEO of Mach One, said, "We are thrilled to have someone with Tad's strong business and financial experience to join our Board. He brings a wealth of business contacts and strategy expertise that will be useful as we continue to execute on our business strategy. I feel that he is the strongest of all the assets being acquired in the Pacific Rim Foods deal."

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected. Readers are encouraged to view the Company's risks identified under the caption "Risk Factors" in the S-1 Registration Statement of the Company as Amended filed with the Securities and Exchange Commission on September 18, 2008.


'/>"/>
SOURCE Mach One Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
2. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
3. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
4. Investor Group Commends Clint Severson for Joining Trinity Biotechs Board of Directors
5. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
6. MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
7. Introducing The Hot Tooth Keyboard, the Cleanable, Hygienic, Wireless Keyboard for Dental Practitioners and Laboratories
8. Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor
9. MedVantx(R) Names Newest Board Member
10. Scott T. Williams Elected to the RetireSafe Board of Directors
11. Encorium Appoints Shahab Fatheazam to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Revolution for Truth has organized the ... parental rights and civil liberties, and to restore transparency within government agencies responsible ... with a press conference taking place Friday morning calling on President Trump to ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... Pittsburgh, PA (PRWEB) , ... March 28, 2017 ... ... built for and by physicians, announced today the launch of a free, public-facing ... The Via Cost Analyzer (VCA) was developed to provide comparative information to patients, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , United Kingdom and  BOSTON , March ... provider Linguamatics today announced a partnership ... . The agreement allows pharmaceutical companies to extract ... I2E text mining technology. ... 18 of the top 20 global pharmaceutical companies. ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: